Navigation Links
Genaera Corporation Announces Licensing of Exclusive Rights to Pexiganan, a Novel Anti-Infective Drug Candidate, by Macrochem Corporation
Date:10/3/2007

e program and the aggressive clinical development of its key assets to build stockholder value. http://www.genaera.com.

About MacroChem

MacroChem Corporation is a specialty pharmaceutical company with two clinical development stage products containing our proprietary enhancer, SEPA(R): EcoNail, to treat fungal infection of the nail and Opterone(R), to treat male hypogonadism. In addition to their SEPA technology, MacroChem is also evaluating applications for MacroDerm(TM), their patented series of polymers that impede penetration of active ingredients through the skin. The in-licensing of pexiganan represents the first product under the Company's previously stated strategy to seek such opportunities to complement its proprietary products based on its transdermal drug delivery technologies. For more information visit their website, http://www.macrochem.com.

This announcement contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties, known and unknown. Forward-looking statements reflect management's current views and are based on certain expectations and assumptions. Such statements include, among others, statements regarding these preliminary results, clinical development plans and prospects for Genaera's programs including trodusquemine (MSI-1436), the IL-9 antibody program, LOMUCIN(TM), or squalamine. You may identify some of these forward-looking statements by the use of words in the statements such as "anticipate," "believe," "continue," "develop," "expect," "plan" and "potential" or other words of similar meaning. Genaera's actual results and performance could differ materially from those currently anticipated and expressed in these and other forward-looking statements as a result of a number of risk factors, including, but not limited to: Genaera
'/>"/>

SOURCE Genaera Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Genaera Discontinues Lomucin in Cystic Fibrosis Studies
2. Chiron Corporation Gets US Contract To Produce Bird Flu Vaccines
3. PM announces a new health care order for India
4. Ramdoss Announces Introduction of RCH-II
5. Britain Announces Third Transfusion Related Mad Cow Case
6. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
7. Tibet Announces the Dalai Lama’s Tour of South Americ
8. NHS announces further Cost cutting Measures
9. Indian PM Announces Of Setting Up India Study Center At Tashkent
10. PowderMed Announces Needle-Less Flu Vaccine
11. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... PA (PRWEB) August 29, 2014 "After reading ... who don’t stand very often, I decided that there needed ... periods during the day," said a concerned inventor from Sikestons, ... stand for long periods. It builds endurance and keeps the ... better health. Easy to use and producible in design variations, ...
(Date:8/29/2014)... Only a handful of CPR and basic life ... which are consistent with recent health guidelines, according ... Medicine Australasia , the journal for the Australasian ... recognition and treatment of sudden cardiac arrest are ... of Turkish emergency medicine specialists put together the ...
(Date:8/29/2014)... The Fresh Diet, America’s premier gourmet meal ... Vegetarian meal plan. Originating from The Fresh Diet’s commitment ... is designed to satisfy customers seeking a convenient, worry-free ... Responding to the growing demand by customers for non-meat ... (Forbes) with 14% of Americans identifying vegetarian meals as ...
(Date:8/29/2014)... Dennis Thompson HealthDay Reporter , ... during the early days of the Ebola outbreak in West ... mutates and spreads. Researchers report in the Aug. 28 ... determined the following: The Ebola strains responsible for ... to the very first recorded outbreak of Ebola in central ...
(Date:8/29/2014)... N.C (PRWEB) August 29, 2014 VHA ... awards for excellence in clinical care, honoring nine facilities ... the patient experience. , “At Novant Health, providing quality, ... top priority” said Tom Zweng, MD, executive vice president ... commitment to provide a remarkable experience for each and ...
Breaking Medicine News(10 mins):Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3
... U.S. wildfires are likely to increase in the coming ... the University of Comahue in Argentina and involving the ... outbreaks in the past five centuries with periods of ... ,States like Washington, Oregon, California, Colorado, New Mexico, Arizona ...
... appears that alcohol-induced bone loss resulting from excessive ... or the anti-osteoporosis drug Boniva? (ibandronate), a Loyola ... binge-alcohol drinking reduces bone mass, which is detrimental ... rate of bone loss in osteoporotic post-menopausal women,” ...
... new virus, a modified strain, has led to the death ... Five other pre mature babies are undergoing treatment. ... University Hospital after they were found to be carriers of ... aureus). ,Hospital authorities have confirmed that the baby ...
... Medicine, doctors report on the case of a 35 ... and emergency department //with double vision, slurred speech, drooping ... to be wound botulism. ,Wound botulism is a ... bacterium Clostridium botulinum contaminate a wound, germinate, and produce ...
... promises heavy investment opportunities for Non-Resident Keralites (NRK), making ... long term. ,Kerala Tourism Department has ... 23 – 27 for showcasing the opportunities in the ... a congregation of major hospitals, health insurance companies, policy ...
... approval for consumption of meat and milk from cloned animals ... and John C. Matheson. have declared that it is safe ... offspring. “On no basis can we differentiate the food products ... ,A formal recommendation will be released this week by ...
Cached Medicine News:Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 2Health News:New Study Links Western Wildfires to Atlantic Ocean Surface Temperatures 3Health News:Vitamin D or Anti-osteoporosis Drug Reduces Bone Loss from Binge Drinking 2
(Date:8/29/2014)... BOSTON , Aug. 29, 2014   Vittamed Corporation ... Boston announced today that T. (Teo) Forcht ... to the company,s Board of Directors. " ... distinguished career in neurosurgery, medical innovation and venture capital," said ... are extremely delighted to add his clinical, strategic, and entrepreneurial ...
(Date:8/29/2014)... , August 29, 2014 ... by Product & Services (Equipment, Reagent, Primer, Probe, ... (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, RNAi) ... the global Oligonucleotide Synthesis Market is expected to ... in 2014, growing at a CAGR of 9.8% ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... Va., Oct. 6 With October ... Association (NCPA) encourages community pharmacists to demonstrate their ... all aspects of medications, from dispensing to disposal. ... (Logo: http://photos.prnewswire.com/prnh/20100106/DC33253LOGO ) ...
... 6 Baxano, Inc. ( www.baxano.com ) today announced that ... Technology for Spine Care at the 2010 Spine Technology Awards. ... first place in the Best New Technology in Lumbar Care. ... 2010 Spine Technology Awards Gala in Orlando, FL. Baxano, Inc. ...
Cached Medicine Technology:NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 2NCPA Encourages Pharmacists to Promote Medication Expertise from Dispensing to Disposal 3Baxano, Inc. Awarded Prestigious 2010 Spine Technology Awards 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: